AAAAAA

   
Results: 1-17 |
Results: 17
Pharmacokinetic parameters of protease inhibitors and the Cmin/IC50 ratio:Call for consensus
Authors: Becker, S Fisher, A Flexner, C Gerber, JG Haubrich, R Kashuba, ADM Luber, AD Piscitelli, SC
Citation: S. Becker et al., Pharmacokinetic parameters of protease inhibitors and the Cmin/IC50 ratio:Call for consensus, J ACQ IMM D, 27(2), 2001, pp. 210-211
Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotyping
Authors: Streetman, DS Kashuba, ADM Bertino, JS Kulawy, R Rocci, ML Nafziger, AN
Citation: Ds. Streetman et al., Use of midazolam urinary metabolic ratios for cytochrome P450 3A (CYP3A) phenotyping, PHARMACOGEN, 11(4), 2001, pp. 349-355
Biological correlates of sexual transmission of HIV: practical consequences and potential targets for public health
Authors: Vernazza, PL Kashuba, ADM Cohen, MS
Citation: Pl. Vernazza et al., Biological correlates of sexual transmission of HIV: practical consequences and potential targets for public health, REV MED MIC, 12(3), 2001, pp. 131-142
Sexual dysfunction and fluvoxamine therapy - Dr. Nafziger and colleagues reply
Authors: Nafziger, AN Bertino, JS Goss-Bley, AI Kashuba, ADM
Citation: An. Nafziger et al., Sexual dysfunction and fluvoxamine therapy - Dr. Nafziger and colleagues reply, J CLIN PSY, 62(2), 2001, pp. 127-128
Domestic cat model for predicting human nucleoside analogue pharmacokinetics in blood and seminal plasma
Authors: Jordan, HL Pereira, AS Cohen, MS Kashuba, ADM
Citation: Hl. Jordan et al., Domestic cat model for predicting human nucleoside analogue pharmacokinetics in blood and seminal plasma, ANTIM AG CH, 45(7), 2001, pp. 2173-2176
Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method
Authors: Ozdemir, V Kalow, W Tang, BK Paterson, AD Walker, SE Endrenyi, L Kashuba, ADM
Citation: V. Ozdemir et al., Evaluation of the genetic component of variability in CYP3A4 activity: a repeated drug administration method, PHARMACOGEN, 10(5), 2000, pp. 373-388
Sexual dysfunction on fluvoxamine therapy - Dr. Nafziger and colleagues reply
Authors: Nafziger, AN Bertino, JS Goss-Bley, AI Kashuba, ADM
Citation: An. Nafziger et al., Sexual dysfunction on fluvoxamine therapy - Dr. Nafziger and colleagues reply, J CLIN PSY, 61(1), 2000, pp. 62-63
Antiretroviral-drug concentrations in semen - Author's reply
Authors: Kashuba, ADM
Citation: Adm. Kashuba, Antiretroviral-drug concentrations in semen - Author's reply, ANTIM AG CH, 44(4), 2000, pp. 1117-1118
Antiretroviral-drug concentrations in semen: Implications for sexual transmission of human immunodeficiency virus type 1 (vol 43, pg 1817, 1999)
Authors: Kashuba, ADM Dyer, JR Kramer, LM Raasch, RH Eron, JJ Cohen, MS
Citation: Adm. Kashuba et al., Antiretroviral-drug concentrations in semen: Implications for sexual transmission of human immunodeficiency virus type 1 (vol 43, pg 1817, 1999), ANTIM AG CH, 44(4), 2000, pp. 1119-1119
Mechanisms of drug interactions
Authors: Kashuba, ADM Bertino, JS
Citation: Adm. Kashuba et Js. Bertino, Mechanisms of drug interactions, INFEC DIS S, 2000, pp. 13-38
Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity
Authors: Kashuba, ADM Nafziger, AN Kearns, GL Leeder, JS Gotschall, R Gaedigk, A Bertino, JS
Citation: Adm. Kashuba et al., Limitations of dextromethorphan N-demethylation as a measure of CYP3A activity, PHARMACOGEN, 9(4), 1999, pp. 453-462
Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy (vol 60, pg 187, 1999)
Authors: Nafziger, AN Bertino, JS GossBley, AI Kashuba, ADM
Citation: An. Nafziger et al., Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy (vol 60, pg 187, 1999), J CLIN PSY, 60(5), 1999, pp. 341-341
Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy
Authors: Nafziger, AN Bertino, JS Goss-Bley, AI Kashuba, ADM
Citation: An. Nafziger et al., Incidence of sexual dysfunction in healthy volunteers on fluvoxamine therapy, J CLIN PSY, 60(3), 1999, pp. 187-190
Improved outcome in fluvoxamine-treated patients with SSRI-induced sexual dysfunction - Reply
Authors: Nafziger, AN Bertino, JS Goss-Bley, AI Kashuba, ADM
Citation: An. Nafziger et al., Improved outcome in fluvoxamine-treated patients with SSRI-induced sexual dysfunction - Reply, J CLIN PSY, 60(12), 1999, pp. 867-868
Antiretroviral-drug concentrations in semen: Implications for sexual transmission of human immunodeficiency virus type 1
Authors: Kashuba, ADM Dyer, JR Kramer, LM Raasch, RH Eron, JJ Cohen, MS
Citation: Adm. Kashuba et al., Antiretroviral-drug concentrations in semen: Implications for sexual transmission of human immunodeficiency virus type 1, ANTIM AG CH, 43(8), 1999, pp. 1817-1826
Optimizing aminoglycoside therapy for nosocomial pneumonia caused by Gram-negative bacteria
Authors: Kashuba, ADM Nafziger, AN Drusano, GL Bertino, JS
Citation: Adm. Kashuba et al., Optimizing aminoglycoside therapy for nosocomial pneumonia caused by Gram-negative bacteria, ANTIM AG CH, 43(3), 1999, pp. 623-629
Nucleoside analogues achieve high concentrations in seminal plasma: Relationship between drug concentration and virus burden
Authors: Pereira, AS Kashuba, ADM Fiscus, SA Hall, JE Tidwell, RR Troiani, L Dunn, JA Eron, JJ Cohen, MS
Citation: As. Pereira et al., Nucleoside analogues achieve high concentrations in seminal plasma: Relationship between drug concentration and virus burden, J INFEC DIS, 180(6), 1999, pp. 2039-2043
Risultati: 1-17 |